ARB-29777-27757 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-01
Dose 1 — Pfizer-BioNTech
2021-04-21
Dose 2 — Pfizer-BioNTech
2021-12-18
Registered in v-safe
2021-12-18
Dose 3 — Pfizer-BioNTech
2021-12-18
Health check-in — day 0, dose 3, dependent
Feeling: Good · Site: Pain · Fever · None

Adult check-in
2021-12-19
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-12-22
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Good · None

Adult check-in
2021-12-23
Health check-in — days 1–6 daily, dose 3, dependent
Feeling: Good · None

Adult check-in
2021-12-26
Survey response — day 7, dose 3, dependent
MedDRA: Cough, Nasopharyngitis — Feeling: Fair · Site: Pain

Free text: Cough and cold

MedDRA releases: 2024-11 · check-in free text available
2022-01-01
Health check-in — day 14, dose 3, dependent
Feeling: Good

Adult check-in
2022-01-08
Health check-in — day 21, dose 3, dependent
Feeling: Good

Adult check-in
2022-01-17
Health check-in — day 28, dose 3, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-01	Pfizer-BioNTech	No
2	2021-04-21	Pfizer-BioNTech	No
3	2021-12-18	Pfizer-BioNTech	No

Free text

Release 10 — day 7, dose 3, dependent

2021-12-26

Systemic reaction (other): Cough and cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Cough	·	·	✓
SRO	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release